SCP Vitalife Partners (Israel) II, L.P., 10% Owner at Recro Pharma, Inc. (REPH), sold 6,090 shares at $9.19 ($56K) on 2017-12-29, disclosed to the SEC on 2018-01-02.
Scheduled sale ($56k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.44 | 1,980 | $19K | 33.1% |
| 2 | $9.19 | 4,110 | $38K | 66.9% |
| Total | $9.27 avg | 6,090 | $56K | 100% |
| Filing → |
| REPH | SELL | 2018-01-08 | $14K | — | Filing → |
| REPH | SELL | 2018-01-04 | $230K | — | Filing → |
| REPH | SELL | 2017-12-28 | $42K | — | Filing → |